- Home
- KIRK vs RADX Comparison
KIRK vs RADX Comparison
Compare KIRK & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- RADX
- Stock Information
- Founded
- KIRK 1966
- RADX 2021
- Country
- KIRK United States
- RADX Australia
- Employees
- KIRK N/A
- RADX N/A
- Industry
- KIRK Diversified Commercial Services
- RADX
- Sector
- KIRK Miscellaneous
- RADX
- Exchange
- KIRK Nasdaq
- RADX NYSE
- Market Cap
- KIRK 26.7M
- RADX 32.5M
- IPO Year
- KIRK 2002
- RADX N/A
- Fundamental
- Price
- KIRK $1.20
- RADX $4.43
- Analyst Decision
- KIRK Buy
- RADX Strong Buy
- Analyst Count
- KIRK 2
- RADX 2
- Target Price
- KIRK $4.50
- RADX $13.50
- AVG Volume (30 Days)
- KIRK 137.7K
- RADX 19.9K
- Earning Date
- KIRK 09-04-2025
- RADX 02-26-2025
- Dividend Yield
- KIRK N/A
- RADX N/A
- EPS Growth
- KIRK N/A
- RADX N/A
- EPS
- KIRK N/A
- RADX N/A
- Revenue
- KIRK $431,111,000.00
- RADX $204,609.00
- Revenue This Year
- KIRK N/A
- RADX N/A
- Revenue Next Year
- KIRK N/A
- RADX N/A
- P/E Ratio
- KIRK N/A
- RADX N/A
- Revenue Growth
- KIRK N/A
- RADX N/A
- 52 Week Low
- KIRK $1.05
- RADX $3.50
- 52 Week High
- KIRK $2.50
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- KIRK 56.91
- RADX N/A
- Support Level
- KIRK $1.13
- RADX N/A
- Resistance Level
- KIRK $1.22
- RADX N/A
- Average True Range (ATR)
- KIRK 0.04
- RADX 0.00
- MACD
- KIRK 0.01
- RADX 0.00
- Stochastic Oscillator
- KIRK 93.06
- RADX 0.00
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.